Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Historical Holders from Q4 2015 to Q3 2025

Symbol
WVE on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
189,947,836
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
143,683,496
Holdings value
$1,051,664,882
% of all portfolios
0.002%
Number of holders
187
Number of buys
92
Number of sells
-79
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 13.4% -8% $169,771,577 25,453,010 0% RA Capital Management, L.P. 11 Dec 2025
Adage Capital Management, L.P. 9.65% +18.8% $115,627,050 +$19,250,000 15,016,500 +20% Adage Capital Management, L.P. 30 Jun 2025
BlackRock, Inc. 6.1% $63,555,507 9,360,163 BlackRock, Inc. 31 Dec 2024
MAVERICK CAPITAL LTD 5.4% $56,093,833 8,261,242 Maverick Capital, Ltd. 31 Dec 2024

Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 143,683,496 $1,051,664,882 +$37,209,339 $7.32 187
2025 Q2 138,939,054 $903,136,388 +$46,387,682 $6.5 174
2025 Q1 131,293,097 $1,061,209,645 +$20,316,471 $8.08 192
2024 Q4 128,616,529 $1,591,015,441 +$86,595,360 $12.37 181
2024 Q3 120,246,621 $986,101,781 +$176,011,863 $8.2 160
2024 Q2 95,071,148 $474,405,111 +$9,854,270 $4.99 143
2024 Q1 92,759,614 $572,308,103 +$4,033,614 $6.17 131
2023 Q4 92,528,153 $468,029,084 +$93,144,169 $5.05 115
2023 Q3 72,598,087 $417,436,128 +$3,006,886 $5.75 85
2023 Q2 72,147,137 $262,614,478 +$6,429,830 $3.64 80
2023 Q1 70,086,593 $303,466,627 +$3,780,454 $4.33 72
2022 Q4 68,108,089 $476,736,473 +$7,420,705 $7 74
2022 Q3 67,256,615 $242,816,542 -$1,613,831 $3.61 58
2022 Q2 67,784,074 $220,297,785 +$69,127,143 $3.25 56
2022 Q1 47,551,964 $95,097,268 -$1,035,989 $2 77
2021 Q4 47,284,486 $148,479,513 +$13,347,500 $3.14 87
2021 Q3 37,428,616 $183,549,240 +$443,975 $4.9 84
2021 Q2 37,041,603 $246,689,021 -$5,849,970 $6.66 82
2021 Q1 38,281,847 $214,782,368 +$1,495,724 $5.61 97
2020 Q4 36,092,793 $284,070,815 -$9,567,182 $7.87 102
2020 Q3 37,117,728 $315,928,313 +$59,335,508 $8.49 106
2020 Q2 29,422,263 $306,287,769 -$6,711,423 $10.41 89
2020 Q1 30,100,828 $282,072,986 +$9,439,494 $9.37 76
2019 Q4 29,498,551 $236,424,963 -$44,351,424 $8.01 87
2019 Q3 30,879,604 $633,634,840 +$1,025,937 $20.53 86
2019 Q2 30,470,000 $794,421,079 +$39,569,951 $26.09 100
2019 Q1 29,400,279 $1,142,135,791 +$191,634,667 $38.85 109
2018 Q4 24,393,021 $1,025,484,934 +$23,061,213 $42.04 91
2018 Q3 23,803,148 $1,190,156,500 -$29,678,796 $50 92
2018 Q2 24,465,339 $935,797,108 +$30,300,014 $38.25 77
2018 Q1 23,663,816 $948,860,012 +$61,087,976 $40.1 79
2017 Q4 22,225,342 $780,113,100 +$59,933,498 $35.1 72
2017 Q3 20,492,602 $445,796,252 +$26,521,810 $21.75 58
2017 Q2 19,316,233 $359,305,882 +$66,970,759 $18.6 55
2017 Q1 15,709,867 $431,755,770 +$32,771,317 $27.5 49
2016 Q4 14,822,157 $388,292,611 +$18,199,344 $26.15 51
2016 Q3 14,061,056 $456,556,375 -$3,399,325 $32.47 45
2016 Q2 14,199,612 $293,778,139 +$6,802,315 $20.69 37
2016 Q1 14,000,592 $192,282,000 +$2,926,211 $13.88 22
2015 Q4 13,788,837 $218,726,000 +$196,226,000 $15.95 18